1. Health Consumers & Patients: Empowering patients offering health monitoring everywhere, every time and without realizing it.
2. Healthcare Providers: Offering rigorous data to clinicians for improve early diagnostic and personalized treatment.
3. Biopharma, CRO and Researchers: Giving more business opportunities to biopharmas, CROs & Research Centers integrating digital measurements across continuum of research and clinical care.
4. Healthcare system sustainability: Improving healthcare sustainability facilitating home hospitalization and real telemedicine
5. Governamental Institutions & Policy Makers: Contribuiting global management of diseases thanks our poblational biometric database.

• Sale of wearables
• Sale of consumables: lactate / glucose sensors
• Database: aggregate studies, anonymized data
• Subscription: Data visualization platform / App customization
• R&D ad hoc contracts with big companies

Our solutions are going to help people with the following needs:

• Chronicpatients & Home Hospitalization
• Home Care & Elderlies
• Diabetes & Nutrition
• Health Sport
• Pediatric & Rare Diseases
• Oncology
• Global Health Cooperation

onalabs has gone through the following milestones since its constitution in 2017:

1. 2017 - Startup
   - Constitution Dec. 2016
   - First Public Grants: EITHealthy SME Phase I
2. 2018 - Development
   - Exclusive licenses from UBU/UPC
   - Start-up Capital ACCIO
   - Accelerated by Ship2B & CIMTI
3. 2019 - Business Consolidation
   - Rebranding & business strategy redefinition
   - NeotecCDTI
4. 2020 - Proof of concept validation
   - Seal of excellence from European Comission
   - CDTI Grant for Home hospitalization
   - AEI:Sport Grant
   - New patent applications
   - US patent granted
5. 2021 - Clinical investigation
   - First successful clinical data validations
   - Startup selected by Roche at Roche Startup Days
   - Startup selected by FCB at Allianz Startup Challenge
   - Andorra startup winner
   - 2 new patent applications
   - Constitution of Onalabs Investment
6. 2022 - Investment Round
   - Successful first clinical pilot validation
   - Investment seed round 1,45M€
   - Winner of Innovation DRAC Prize of RAC1
   - Winner of Innovation Cerdanyola Empresarial Price
   - Constitution of OnalabsDigital Health AD